A commercial extract of fruits and vegetables, oxxynea, acts as a powerful antiatherosclerotic supplement in an animal model by reducing cholesterolemia, oxidative stress, and NADPH oxidase expression

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 10, 2007, Pages 4258-4263

  Sutra, Thibault ^a   Décordé, Kelly ^a   Riss, Jérome ^a   Dallas, Constant ^b   Cristol, Jean Paul ^a   Rouanet, Jean Max ^a  

^a UNIV MONTPELLIER   (France)

^b Nutraceutic Business Consulting (NB Consulting)   (France)

Author keywords

Antioxidant compounds; Atherosclerosis; Fruits and vegetables; Hamsters; NADPH oxidase

Indexed keywords

CHOLESTEROL; OXXYNEA; PLANT EXTRACT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ANIMAL; ATHEROSCLEROSIS; BLOOD; CHEMISTRY; CONFERENCE PAPER; DISEASE MODEL; DRUG EFFECT; FRUIT; GENE EXPRESSION; GENETICS; HAMSTER; MALE; OXIDATIVE STRESS; SYRIAN HAMSTER; VEGETABLE;

ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; CRICETINAE; DISEASE MODELS, ANIMAL; FRUIT; GENE EXPRESSION; MALE; MESOCRICETUS; NADPH OXIDASE; OXIDATIVE STRESS; PLANT EXTRACTS; VEGETABLES;

ANIMALIA; CRICETINAE;

EID: 34249883350     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf070029n     Document Type: Conference Paper

References (41)

1. Ross, R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 1999, 340, 115-26.
2. Frei, B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am. J. Med. 1994, 97, 5S-13S, 22S-8S.
3. Guzik, T. J.; West, N. E.; Black, E.; McDonald, D.; Ratnatunga, C.; Pillai, R.; Channon, K. M. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ. Res. 2000, 86, E85-90.
4. Lassegue, B.; Clempus, R. E. Vascular NAD(P)H oxidases : specific features, expression, and regulation. Am. J. Physiol.: Regul., Integr. Comp. Physiol. 2003, 285, R277-97.
5. Szöcs, K.; Lassegue, B.; Sorescu, D.; Hilenki, L. L.; Valppu, L.; Couse, T. L.; Wilcox, J. N.; Quinn, M. T.; Lambeth, J. D.; Griendling, K. K. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler., Thromb., Vasc. Biol. 2002, 22, 21-7.
6. Azumi, H.; Inoue, N.; Takeshita, S.; Rikitake, Y.; Kawashima, S.; Hayashi, Y.; Itoh, H.; Yokoyama, M. Expression of NADH/ NADPH oxidase p22phox in human coronary arteries. Circulation 1999, 100, 1494-8.
7. Aviram, M. Modified forms of LDL and atherosclerosis. Atherosclerosis 1993, 98, 1-9.
8. Aviram, M.; Rosenblat, M.; Etzioni, A.; Levy, R. Activation of NADPH oxidase required for macrophage-mediated oxidation of low-density lipoprotein. Metabolism 1996, 45, 1069-79.
9. Heinloth, A.; Heermeyer, K.; Raff, U.; Wanner, C.; Galle, J. Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells. J. Am. Soc. Nephrol. 2000, 11, 1819-25.
10. Zhao, G. F.; Sen, J. J.; Zhang, H.; She, M. P. Effects of oxidized low density lipoprotein on the growth of human artery smooth muscle cells. Chin. Med. J. (Beijing, Engl. Ed.) 2005, 118, 1973-8.
11. Block, G. The data support a role for antioxidants in reducing cancer risk. Nutr. Rev. 1992, 50, 207-13.
12. Parodi, P. W. The French paradox unmasked: the role of folate. Med. Hypotheses 1997, 49, 313-8.
13. Hertog, M. G.; Kromhout, D.; Aravanis, C.; Blackburn, H.; Buzina, R.; Fidanza, F.; Giampaoli, S.; Jansen, A.; Menotti, A.; Nedeljkovic, S. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 1995, 155, 381-6.
14. Frankel, E. N.; Kanner, J.; German, J. B.; Parks, E.; Kinsella, J. E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993, 341, 454-7.
15. Bravo, L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 1998, 56, 317-33.
16. Duthie, G.; Crozier, A. Plant-derived phenolic antioxidants. Curr. Opin. Lipid 2000, 11, 43-7.
17. Orallo, F.; Alvarez, E.; Camina, M.; Leiro, J. M.; Gomez, E.; Fernandez, P. The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol. Pharmacol. 2002, 61, 294-302.
18. Adams, M. R.; Golden, D. L.; Chen, H.; Register, T. C.; Gugger, E. T. A diet rich in green and yellow vegetables ihibits atherosclerosis in mice. J. Nutr. 2006, 136, 1886-89.
19. Nicolle, C.; Cardinaut, M.; Aprikian, O.; Busserolle, J.; Grolier, P.; Rock, E.; Demigné, C.; Mazur, A.; Sclabert, A.; Amouroux, P.; Rémézy, C. Effect of a carrot intake on cholesterol metabolism and on anti-oxidant status in cholesterol-fed rat. Eur. J. Nutr. 2003, 42, 254-61.
20. Nicolle, C.; Cardinaut, M.; Gueux, E.; Jaffrelo, L.; Rock, E.; Mazur, A.; Amouroux, P.; Rémézy, C. Health effect of vegetable-based diet : lettuce consumption improves cholesterol metabolism and antioxidant status in the rat. Clin. Nutr. 2004, 23, 605-14.
21. Auger, C.; Teissèdre, P. L.; Gérain, P.; Lequeux, N.; Bornet, A.; Serisier, S.; Besançon, P.; Caporiccio, B.; Cristol, P.; Rouanet, J. M. Dietary wine phenolics catechin, quercetin and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. J. Agric. Food Chem. 2005, 53, 2015-21.
22. Auger, C.; Caporiccio, B.; Landrault, N.; Teissèdre, P. L.; Laurent, C.; Cros, G.; Besançon, P.; Rouanet, J. M. Red wine phenolic compounds reduce plasma lipids and apolipoprotein B, and prevent early aortic atherosclerosis in hypercholesterolemic Golden Syrian hamsters (Mesocricetus auratus). J. Nutr. 2002, 132, 1207-13.
23. Vinson, J. A.; Teufel, K.; Wu, N. Red wine, dealcoholized red wine, and espacially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis 2001, 156, 67-72.
24. Kowala, M. C.; Nunnari, J. J.; Durham, S. K.; Nicolosi, R. J. Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters. Atherosclerosis 1991, 91, 35-49.
25. Ou, B.; Hampsch-Woodill, M.; Prior, R. L. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J. Agric. Food Chem. 2001, 49, 4619-26.
26. Davalos, A.; Gomez-Cordoves, C.; Bartolomé, B. Extending applicability of oxygen radical absorbance capacity (ORAC-Fluorescein) assay. J. Agric. Food Chem. 2004, 52, 48-54.
27. National Research Council. Guide for the Care and the Use of Laboratory Animals. Publication no. 85-23(rev.); National Institutes of Health: Bethesda, MD, 1985.
28. Reeves, P. C.; Nielsen, F. H.; Fahey, G. C., Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76 rodent diet. J. Nutr. 1993, 123, 1939-51.
29. Rice-Evans, C.; Miller, N. J. Total antioxidant status in plasma and body fluids. Methods Enzymol. 1994, 234, 279-93.
30. Koechlin, C.; Couillard, A.; Cristol, J. P.; Chanez, P.; Hayot, M.; Le Gallais, D.; Prefaut, C. Does systemic inflammation trigger local exercise-induced oxidative stress in COPD? Eur. Respir. J. 2004, 23, 538-44.
31. Nunnari, J. J.; Zand, T.; Joris, I.; Majno, G. Quantification of Oil red O staining of the aorta in hypercholesterolemic rats. Exp. Mol. Pathol. 1989, 51, 1-8.
32. Delbosc, S.; Paizanis, E.; Magous, R.; Araiz, C.; Dimo, T.; Cristol, J. P.; Cros, G.; Azay, J. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 2005, 179, 43-9.
33. Nikkari, S. T.; Salokivi, T.; Jaakkola, O. The hyperlipidemic hamster as an atherosclerosis model. Artery 1991, 18, 285-90.
34. Delbosc, S.; Cristol, J. P.; Descomps, B.; Nimran, A.; Jover, B. Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress. Hypertension 2002, 40, 142-7.
35. Matsumoto, T.; Miyamori, K.; Kobayashi, T.; Kamata, K. Apocynin normalizes hyperreactivity to phenylephrine in mesenteric arteries from cholesterol-fed mice by improving endothelium-derived hyperpolarizing factor response. Free Radical Biol. Med. 2006, 41, 1289-303.
36. Maeda, K.; Yasunari, K.; Sato, E. F.; Inoue, M. Enhanced oxidative stress in neutrophils from hyperlipidemic guinea pig. Atherosclerosis 2005, 181, 87-99.
37. Witzum, J. L.; Steinberg, D. Role of oxidized lipoprotein in atherogenesis. J. Clin. Invest. 1991, 88, 1785-92.
38. +, AAPH or SIN-1 and at decreasing superoxide THP-1 cell production. A comparison to other extracts or compounds. Free Radical Res. 2003, 37, 573-84.
39. Georgescu, A.; Alexandra, M.; Constantinescu, E.; Popo, B. Effect of gap junction uncoupler heptanol on resistance arteries reactivity in experimental model of diabetes, hyperlipemia and hyperlipemia-diabetes. Vasc. Pharmacol. 2006, 44, 513-8.
40. Wagner, A. H.; Kohler, T.; Ruckschloss, U.; Just, I.; Hecker, M. Improvement of nitric oxide-dependent vasodilatation by HMGCoA reductase inhibitor through attenuation of endothelial superoxide anion formation. Arterioscler., Thromb., Vasc. Biol. 2000, 20, 61-9.
41. Al-Awwadi, N. A.; Araiz, C.; Bornet, A.; Delbosc, S.; Cristol, J. P.; Linck, N.; Azay, J.; Teissedre, P. L.; Cros, G. Extracts enriched in different polyphenols families normalize increased cardiac NADPH oxidase expression while having differential effects on insulin resistance, hypertension, and cardiac hypertrophy in high-fructose-fed rats. J. Agric. Food Chem. 2005, 53, 151-7.